German chemicals, pharmaceuticals and life sciences group Merck, which operates its Healthcare business as EMD Serono in the US and Canada, announced that it plans to...
Ahead of a change in leadership at the top after the upcoming annual general meeting, in interviews with news agencies Bayer is dropping hints in dribbles about future...
As part of what seems to be a general pattern of staff reductions in the pharmaceutical industry worldwide, a growing number of Western drugmakers are downsizing their...
As the discussion surrounding the high price of insulin in the US continues unabated, drugmaker Eli Lilly implemented price reductions of 70% for its most commonly...
Amgen’s proposed acquisition of Horizon Therapeutics for $28.7 billion, including debt, would be the largest healthcare deal since AstraZeneca’s $39 billion purchase of...
Sanner, a German manufacturer of pharmaceutical primary packaging and medical technology products, is expanding capacity. The company broke ground in January on a new...
In a move to advance productivity, the healthcare division of Germany’s Merck is realigning its drug discovery and launch strategy. Global healthcare research chief Danny...
